Guoyu Huang

Haikou, 570100, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

SIRT7: A potential prognostic marker and therapeutic target in gallbladder cancer.

SIRT7: A potential prognostic marker and therapeutic target in gallbladder cancer.

Journal: Pathology, research and practice

Published: July 06, 2023

SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.

SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.

Journal: Cell division

Published: February 04, 2023

Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.

Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 13, 2022

SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.

SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.

Journal: Scientific reports

Published: April 13, 2022

SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.

SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.

Journal: OncoTargets and therapy

Published: April 18, 2019

Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer.

Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer.

Journal: OncoTargets and therapy

Published: June 22, 2018

Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.

Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.

Journal: Oncology letters

Published: March 22, 2018

SIRT4 is upregulated in breast cancer and promotes the proliferation, migration and invasion of breast cancer cells.

SIRT4 is upregulated in breast cancer and promotes the proliferation, migration and invasion of breast cancer cells.

Journal: International journal of clinical and experimental pathology

Published: October 24, 2017

Decreased SIRT4 protein levels in endometrioid adenocarcinoma tissues are associated with advanced AJCC stage.

Decreased SIRT4 protein levels in endometrioid adenocarcinoma tissues are associated with advanced AJCC stage.

Journal: Cancer biomarkers : section A of Disease markers

Published: June 07, 2017

Erratum: Differential expression of miR-21 and miR-75 in esophageal carcinoma patients and its clinical implication.

Erratum: Differential expression of miR-21 and miR-75 in esophageal carcinoma patients and its clinical implication.

Journal: American journal of translational research

Published: January 24, 2017

Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.

Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.

Journal: Oncology reports

Published: December 13, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026